Published in Annu Rev Public Health on January 01, 1988
Free-alcohol policy on airlines. CMAJ (1988) 1.37
Caring for unhealthy lifestyles. CMAJ (1994) 0.96
Equality and difference: persisting historical themes in health and alcohol policies affecting Indigenous Australians. J Epidemiol Community Health (2007) 0.87
Epidemiology of alcoholic cirrhosis. Australas Ann Med (1969) 1.39
Screening for problem drinking and counseling by the primary care physician-nurse team. Alcohol Clin Exp Res (1996) 1.38
Physical disease in alcoholism. Initial survey of 1,000 patients. Med J Aust (1971) 1.33
Liver in ulcerative colitis: obstructive jaundice due to bile duct carcinoma. Gut (1966) 1.29
Morbidity in alcoholics. Evidence for accelerated development of physical disease in women. Arch Intern Med (1977) 1.26
Cerebral atrophy and functional deficits in alcoholics without clinically apparent liver disease. Neurology (1981) 1.21
The physical disease characteristics of inpatient alcoholics. J Stud Alcohol (1981) 1.20
Alcohol consumption and hypertension--the evidence from hazardous drinking and alcoholic populations. Aust N Z J Med (1979) 1.16
Support among smokers and nonsmokers for restrictions on smoking. Am J Prev Med (1996) 1.09
Effect of short-term therapy with propylthiouracil in patients with alcoholic liver disease. Gastroenterology (1979) 1.08
Collagenisation of the Disse space in alcoholic liver disease. Gut (1979) 1.07
Preventing alcohol problems: survey of Canadian medical schools. CMAJ (1990) 1.05
Alcoholic liver disease: the problem of diagnosis. Alcohol Clin Exp Res (1978) 1.01
Risk of fatty infiltration or cirrhosis of the liver in relation to ethanol consumption: a case-control study. Clin Invest Med (1986) 0.99
Preventing alcohol problems: preparing physicians for their roles and responsibilities. CMAJ (1990) 0.98
Effect of alcohol on haemopoiesis. Br Med J (1966) 0.96
Hazardous alcohol consumption and diseases of the circulatory system. J Stud Alcohol (1980) 0.92
Seroprevalence of and risk factors for HIV-1 infection in injection drug users in Montreal and Toronto: a collaborative study. CMAJ (1993) 0.91
Relationship between smoking and pulmonary disease in alcoholism. Med J Aust (1969) 0.89
Cost without benefit? The introduction of hepatitis B vaccine in Canada. Can Med Assoc J (1983) 0.89
Changing trends of cirrhosis mortality in Ontario, Canada, 1911-1986. Int J Epidemiol (1991) 0.88
Alcohol and acetaldehyde metabolism in Caucasians, Chinese and Amerinds. Can Med Assoc J (1976) 0.87
Needle sharing behaviour among injection drug users (IDUs) in treatment in Montreal and Toronto, 1988-1989. Can J Public Health (1992) 0.86
An agenda for action. CMAJ (1990) 0.84
An efficacy trial of a mammalian cell-derived recombinant DNA hepatitis B vaccine in infants born to mothers positive for HBsAg, in Shanghai, China. Int J Epidemiol (1992) 0.83
Morbidity patterns in hazardous drinkers: relevance of demographic, sociologic, drinking, and drug use characteristics. Int J Addict (1981) 0.82
Bromsulphthalein metabolism in acute alcoholic liver disease. Gut (1968) 0.81
Relationship between hepatitis B surface antigen prevalence, per capita alcohol consumption and primary liver cancer death rate in 30 countries. J Clin Epidemiol (1988) 0.80
A randomized double-blind clinical trial of a mammalian cell-derived recombinant DNA hepatitis B vaccine compared with a plasma-derived vaccine. Arch Intern Med (1990) 0.78
The spectrum of liver diseases in alcoholism. Aust N Z J Med (1975) 0.78
Skid row alcoholism. A distinct sociomedical entity. Arch Intern Med (1976) 0.77
'Mixed' (drug abusing) and 'pure' alcoholics: a socio-medical comparison. Br J Addict Alcohol Other Drugs (1978) 0.76
Social class and morbidity in clinically treated alcoholics. Drug Alcohol Depend (1976) 0.75
Alcohol degradation and bromsulphthalein metabolism in acute alcoholic liver disease. Gut (1969) 0.75
"Continuous" and "intermittent" alcoholics: a comparison of demographic, sociological, and physical disease characteristics in relation to the pattern of drinking. Addict Dis (1976) 0.75
A method for estimating "persons" versus "cases" from hospital morbidity data in the absence of unique personal identifiers. Am J Epidemiol (1987) 0.75
Epidemiology of alcoholism: social data and drinking patterns of a sample of Australian alcoholics. Med J Aust (1969) 0.75
Relationship between liver cirrhosis death rate and nutritional factors in 38 countries. Int J Epidemiol (1988) 0.75
A litany: hopeful or monotonous and ineffective? Med J Aust (1978) 0.75
Dependence on ACTH. Ann Intern Med (1972) 0.75
The general hospital: a sphere of social medicine? Med J Aust (1969) 0.75
Teaching medical students about alcoholism. Can Med Assoc J (1984) 0.75
Abnormality of liver function in porphyria cutanea tarda symptomatica. Gut (1969) 0.75
The Australian Medical and Professional Society on Alcohol and other Drugs: The first 10 years and beyond. The 1st James Rankin Oration. Drug Alcohol Rev (1991) 0.75
Community-based facilities may be replacing hospitals for the treatment of alcoholism: the evidence from Ontario. Am J Drug Alcohol Abuse (1994) 0.75
Studies in alcoholism. I. A general hospital medical clinic for the treatment of alcoholism. Med J Aust (1967) 0.75
Bromism in association with alcoholism: a report of five cases. Med J Aust (1969) 0.75
A role for prostaglandins in the regulation of the placental blood flows. Prostaglandins (1976) 0.75
Alcoholism And Drug Addiction Research Foundation of Ontario: research goals and plans. Ann N Y Acad Sci (1976) 0.75
Mortality and hospital morbidity from cirrhosis of the liver in relation to per capita consumption of absolute alcohol, education and native status, Ontario; 1978 to 1982. Clin Invest Med (1989) 0.75
Hospital morbidity from cirrhosis of the liver and per capita consumption of absolute alcohol in Ontario, 1978 to 1982: a descriptive analysis. Can J Public Health (1988) 0.75
Selective deficiency of IgA immunoglobulins associated with carcinoma of the stomach. Australas Ann Med (1970) 0.75
Epidemiology of alcohol abuse. Med J Aust (1970) 0.75
Hepatitis B markers and risk factors for hepatitis B in liver biopsy patients. Clin Invest Med (1986) 0.75
Bromureide dependence in alcoholics. Med J Aust (1971) 0.75